- Uganda officials confirmed an Ebola outbreak in the capital of the country of East Africa, Kampala, last week.
- A nurse died on January 29, and the Ugandan authorities have confirmed two other cases of Ebola to the announcement of the outbreak.
- The director of the World Health Organization for Africa said that Uganda has begun a clinical trial of a vaccine against Ebola Sudan strain, for which there is currently no approved vaccine.
Uganda has begun a test vaccination program for the volume of the viral ebola infection that is behind the last outbreak of the country, according to the World Health Organization (WHO), while the number of confirmed cases has increased to three.
Last week, the Eastern Africa country announced an Ebola outbreak in the capital, Kampala, with a single case, a nurse who died on January 29.
The CDC ordered to stop collaborating immediately with whom after Trump begins to process for the US withdrawal.
The total number of cases has now increased to three, with the two additional cases of the family of the deceased man, the spokesman of the Ministry of Health, Emmanuel Ainebyaona, on Monday night, told Reuters.
In a publication on platform X on Monday night, Matshidiso Moeti, director of Africa, said that Uganda had also started a clinical trial of a vaccine against Ebola Sudan strain.
A Uganda doctor serves a patient who had positive during the launch of the Vaccination of Sudan strain of the Ebola virus in the insulation center of the Mulago guest house in Kampala, Uganda, on February 3, 2025 . (Reuters/Abubaker Lubowa)
Currently, there is no approved vaccine for that strain. The existing vaccination is for the Zaire strain, which is behind a recent outbreak in the neighboring democratic republic of the Congo.
“This marks an important milestone in the Public Health emergency response and demonstrates the power of collaboration for global health security,” Moeti said. “If it is shown that the vaccine will even more strengthen measures to protect future outbreaks.”
Click here to get the Fox News application
Bruce Kirenga, who runs the Lung Lung Institute, a research organization that is making the trial, told local media during the launch of vaccination that had been developed by the International AIDS vaccine initiative (IAVI) and that the Institute had received around 2,460 doses.
The Ministry of Health said last week that the trial would direct confirmed cases contacts.
A highly ease disease, the symptoms of ebola infection include bleeding, headache and muscle pains. The virus is transmitted through contact with infected body fluids and tissue.